Peptide directoryGut, pancreas & liver

Neurotensin

A gut and brain peptide released by fat, now watched in obesity and cancer.

Where it comes from

Made in
N cells of the ileum; neurons in the hypothalamus, brainstem and reward pathways
Sent out by
Fat in the gut above all; in the brain, alongside dopamine
Acts on
  • Gut (motility and fat absorption)
  • Dopamine neurons
  • Hypothalamus

What it does

  • Promotes the absorption of fat in the gut 2
  • Lowers blood pressure and body temperature when given
  • In the brain it modulates dopamine, pain and feeding 2

In medicine

  • No medicine. Pro-neurotensin in blood predicted new diabetes, cardiovascular disease, breast cancer and death in a large Swedish cohort 1, and has since been linked with fatty liver and stroke in others
  • NTSR1 is over-expressed in pancreatic and other cancers and is the target of experimental radioligands 3

Beyond the body’s own use

  • NTSR1 agonists are studied as antipsychotics and as non-opioid analgesics in animals. None has reached a trial in people, because activating the receptor also drops blood pressure and body temperature 2
  • A lutetium-177 NTSR1 radioligand has been given to a handful of people with metastatic pancreatic cancer, with tumour shrinkage in some and no approval 3
  • Pro-neurotensin is a research measure, not a clinical test: the association with later disease is consistent but nobody has shown that changing neurotensin changes the risk 1

Sources

  1. Melander et al., Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer and mortality, JAMA 2012
  2. Thompson et al., Influence of the neurotensin signalling system on feeding and satiety, Neuropharmacology 2025
  3. Baum et al., Lutetium-177-3BP-227 for neurotensin receptor 1-targeted therapy of metastatic pancreatic adenocarcinoma, Journal of Nuclear Medicine 2018

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.